Adult classical Hodgkin's lymphoma-care pathway
Hodgkin's lymphoma is a tumor proliferation of lymphoid cells in one or more lymphoid organs, sometimes with extension in extra-ganglion sites. It differs from non-Hodgkin (NHL) lymphomas by the presence of large, morphologically and immunologically characteristic tumor cells: Reed-Sternberg cells, a more frequently localized clinical presentation and a Overall better prognosis.
In 2011, about 1 840 new cases of Hodgkin's lymphoma were diagnosed in France, or 0.5% of all cancers. Its overall impact remains stable. There are two peaks of incidence: one in the young adult (20-30 years) and a second in the subject aged over 60 years.
Hodgkin's lymphoma is a good prognosis cancer. With a 5-year survival rate of 84% all forms, it is one of the most curable cancers with the best prognosis in the long term. In France, it resulted in the death of just under 300 patients in 2011, or 0.2% of cancer deaths.
0 comments:
Post a Comment